TPI 287 in Patients With Recurrent Glioblastoma Multiforme
NCT01113463
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class
Stopped
Low Accrual
Conditions
Brain Cancer
Interventions
DRUG:
TPI 287
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]